Fig. 1From: Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)Study design. GnRHa, gonadotropin-releasing hormone agonist; r-hFSH, recombinant human follicle stimulating hormone; hCG, human chorionic gonadotropin; ẞ-hCG, beta-human chorionic gonadotropin; w, weeks; d, days; hrs, hoursBack to article page